(NASDAQ: NTRA) Natera's forecast annual revenue growth rate of 12.68% is forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 5.17%, and it is also forecast to beat the US market's average forecast revenue growth rate of 9.84%.
Natera's revenue in 2025 is $1,831,000,000.On average, 7 Wall Street analysts forecast NTRA's revenue for 2025 to be $272,051,446,141, with the lowest NTRA revenue forecast at $269,650,820,718, and the highest NTRA revenue forecast at $273,912,439,480. On average, 7 Wall Street analysts forecast NTRA's revenue for 2026 to be $314,414,339,853, with the lowest NTRA revenue forecast at $302,409,710,726, and the highest NTRA revenue forecast at $325,131,061,638.
In 2027, NTRA is forecast to generate $366,530,619,228 in revenue, with the lowest revenue forecast at $346,809,196,679 and the highest revenue forecast at $381,867,531,094.